Ambryon Biosciences

AAV cis-regulatory sequences are correlated with ocular toxicity

Xiong et al. (2019). Proc Natl Acad Sci USAResearch

Ocular AAV vectors were considered safe, though high doses were toxic in animals. Subretinal injections in neonatal mice tied toxicity to the promoter, not capsid or transgene. AAV8 with CMV, CAG, UbiC or Best1 was toxic and four photoreceptor-specific promoters were not.

Key findings

  • AAV8-CMV-GFP at 8E8 or 3E9 vg per eye in neonatal CD-1 mice shortens cone outer segments, thins the outer nuclear layer and raises Müller glia GFAP at P30; RedO, Rho, RK or CAR promoters cause none at top doses.

  • Damage from toxic AAV8-CMV-GFP in mouse retina and RPE stays within the infected area: with partial infection, toxicity does not extend beyond GFP-positive regions, and RPE loss and cone outer segment loss usually coincide.

  • High-dose AAV8-CMV-GFP in P0 C57BL/6J mice impairs function versus a nontoxic RedO plus Best1 mix (5:1): scotopic ERG a-wave falls 84% (P < 0.001), b-wave 71%, photopic b-wave 50-70% with fivefold higher I1/2, and optomotor acuity 30% (P < 0.05).

  • Low-dose AAV8-CMV-GFP deficits are milder but dose-scaled: versus RedO plus Best1 (5:1) in P0 C57BL/6J mice, scotopic a-wave falls 49% (P < 0.05), b-wave delays 27 ms (P < 1E-8), photopic I1/2 roughly doubles (9.0 versus 4.8 cd s/m2).

  • Toxic AAV8-CMV-GFP activates microglia: at 3E9 vg per eye, P30 retinas show more Iba1-positive amoeboid microglia in the outer nuclear layer and subretinal space, already at 8E8, unlike AAV8-RedO-GFP; in Cx3cr1-GFP mice, 3E8 vg AAV8-CMV-TdTomato raises GFP-positive microglia threefold.

  • Retinas infected with toxic AAV8 vectors strongly up-regulate TNF-α and IL-1β mRNAs at P30 (qPCR, 3E9 vg per eye) while IL-6 and IFN-γ do not change significantly; TNF-α and IL-1β expression rises with dose.

  • AAV8 with CMV, CAG, UbiC or RPE-specific Best1 promoters is toxic to RPE, whereas RedO, Rho, RK or CAR photoreceptor promoters are not, in P0 CD-1 mice at P30 (8E8 vg per eye, 3E9 for CAR); damage is long-lasting.

  • AAV8 ocular toxicity in mice does not track with preparation: stocks made by several methods in one laboratory and by three virus core facilities are all toxic, protein contaminants do not correlate with toxicity, and endotoxin is very low.

  • CMV-GFP genomes are toxic to the mouse eye packaged in AAV8, AAV5, Anc80 or AAV2-derived 7m8, delivered subretinally, so toxicity is not restricted to one capsid; toxicity is also seen in albino CD-1 and pigmented C57BL/6J mice.

  • In C57BL/6J mice, AAV8- or AAV5-CMV-GFP at 8E8 vg per eye disrupts OCT outer limiting membrane, IS/OS and RPE bands; at 3E9 it thins the outer nuclear layer and is consistent with RPE death, while AAV8-CAR-GFP leaves layers largely normal.

  • RPE toxicity of AAV8-CMV-GFP is dose-dependent in neonatal CD-1 mice at P30: 5E8 vg per eye causes RPE enlargement with some loss (about grade 3 on the phalloidin scale), 2E9 vg per eye nearly complete loss (about grade 5).

  • In neonatal CD-1 mice photoreceptors tolerate AAV8-CMV-GFP better than RPE: at 1E9 and 2E9 vg per eye cone outer segments are largely absent, but at 5E8 RPE is abnormal while cone outer segments are largely normal.

Author abstract

Significance Adeno-associated viral (AAV) gene therapy is becoming an important therapeutic modality, especially for ocular diseases, due to its efficiency of gene delivery and relative lack of pathogenicity. However, AAV sometimes can cause inflammation and toxicity. We explored such effects using injections into the mouse eye. We found a strong correlation of toxicity and inflammation with the use of promoters that were broadly active, or specifically active in the retinal pigment epithelium. AAVs with photoreceptor-specific promoters were found to be nontoxic at all doses tested. These studies reveal that safer vectors can be designed if assays for relevant and specific cell types are developed and tested with a range of vectors with different genomic elements.

Identifiers & revision